Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
Citi
Fish and Richardson
Fuji
Argus Health
Deloitte
UBS

Generated: April 21, 2018

DrugPatentWatch Database Preview

CYCLOGYL Drug Profile

« Back to Dashboard

Which patents cover Cyclogyl, and what generic alternatives are available?

Cyclogyl is a drug marketed by Alcon Labs Inc and is included in three NDAs.

The generic ingredient in CYCLOGYL is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Drug patent expirations by year for CYCLOGYL
Medical Subject Heading (MeSH) Categories for CYCLOGYL
Synonyms for CYCLOGYL
(+-)-cyclopentolate HCl
(+/-)-Cyclopentolate Hydrochloride
2-(2-(1-Hydroxycyclopentyl)-2-phenylacetoxy)ethyldimethylammonium chloride
2-(Dimethylamino)ethyl (+-)-1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate hydrochloride
2-(Dimethylamino)ethyl 1-Hydroxy-|A-phenylcyclopentaneacetate Hydrochloride
2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate hydrochloride
2-(Dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;hydrochloride
2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
5870-29-1
870C291
AC-27486
AC1L2JUE
AK-Pentolate
AK144155
AKOS015901379
Akpentolate
Alnide
AN-20017
Benzeneacetic acid, ?-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, (+-)-
beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate hydrochloride
CAS-5870-29-1
CC0260
CCG-39635
CHEBI:4025
CHEMBL1200473
Ciclolux
Cicloplegicedol
Cyclogyl (TN)
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester,hydrochloride
Cyclopentolate for system suitability, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate HCL
CYCLOPENTOLATE HYDROCHLORIDE
Cyclopentolate hydrochloride (JP17/USP)
Cyclopentolate hydrochloride [USAN:JAN]
Cyclopentolate hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate hydrochloride, United States Pharmacopeia (USP) Reference Standard
Cyplegin
D01002
DSSTox_CID_25390
DSSTox_GSID_45390
DSSTox_RID_80847
DTXSID9045390
EINECS 227-521-8
FT-0603161
HMS1571K12
HMS1920A22
I14-15042
LS-57811
MFCD00079048
MLS000069583
MLS001148637
MLS001332539
MLS001332540
MolPort-003-666-151
Mydplegic
NCGC00016661-01
NCGC00018213-06
NCGC00094635-01
NCGC00094635-02
NCGC00094635-03
NCGC00094635-04
NSC-756706
NSC756706
Opera_ID_69
OR147284
Pentolair
Pharmakon1600-01500212
REGID_for_CID_22162
SC-81592
SCHEMBL24612
Skiacol
SMR000058810
SPECTRUM1500212
ST24039645
Tox21_110550
Tox21_110550_1
Y0424
Zyklolat

US Patents and Regulatory Information for CYCLOGYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084109-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084110-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084108-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Citi
AstraZeneca
Cantor Fitzgerald
US Department of Justice
QuintilesIMS
McKesson
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.